Carl Counsell

Developing predictive models of excellent and devastating outcome after stroke.

S. Phillips, C. Counsell, D. Dai, 2012, Age and ageing.

Spatial channels of visual processing in cortical blindness

Lawrence Weiskrantz, Arash Sahraie, Mary Joan MacLeod, 2003, The European journal of neuroscience.

Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism

Robert Caslake, C. Counsell, C. Harris, 2008 .

Predicting Outcome After Acute and Subacute Stroke: Development and Validation of New Prognostic Models

C. Warlow, M. Dennis, C. Counsell, 2002, Stroke.

Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing

Jean-François Dartigues, Günther Deuschl, Yoav Ben-Shlomo, 2017, Genome Biology.

Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients

Richard Gray, Keith Wheatley, Carl E Clarke, 2004, BMJ : British Medical Journal.

Systematic Review of Prognostic Models in Patients with Acute Stroke

M. Dennis, C. Counsell, Carl Counsell, 2001, Cerebrovascular Diseases.

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

Peter Sandercock, Joanna Wardlaw, G Middleton, 1997, The Lancet.